Venture Certified
| 기술평가보증기업(기금) | 2012-03-27 ~ 2014-03-26 | 20120102529 | 2012-03-27 |
| 기술평가보증기업(기금) | 2014-03-27 ~ 2016-03-26 | 20140102956 | 2012-03-27 |
| 연구개발유형 | 2016-03-27 ~ 2018-03-26 | 20160105786 | 2012-03-27 |
| 연구개발유형 | 2018-03-27 ~ 2020-03-26 | 20180102860 | 2012-03-27 |
| 벤처투자유형 | 2020-03-27 ~ 2022-03-26 | 20200300202 | 2012-03-27 |
| 벤처투자유형 | 2022-03-27 ~ 2025-03-26 | 20220428010023 | 2012-03-27 |
| 벤처투자유형 | 2025-03-27 ~ 2028-03-26 | 20250429010010 | 2012-03-27 |
Revenue CAGR +24.5%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 22.3B | 14.1B | 14.4B |
| Operating Profit | -18.6B | -56.2B | -43.3B |
| Net Profit | -20.0B | -38.4B | -72.3B |
| Total Assets | 25.1B | 46.0B | 46.0B |
| Total Liabilities | 306.7B | 225.9B | 217.2B |
| Total Equity | -281.7B | -179.9B | -171.2B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -19B
3 Consecutive Years of Net Loss
▲ 56.7%
▲ 62.7%
▲ 76.2%
▲ 13.7%
▼ 77.7%
| Name | Position | Role |
|---|---|---|
| 박현숙 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 종로구",
"ceo_name": "박현숙",
"certificate": [
{
"cert_number": "20120102529",
"changes": "",
"disclosure_date": "2012-03-27",
"first_cert_date": "2012-03-27",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-03-27 ~ 2014-03-26"
},
{
"cert_number": "20140102956",
"changes": "",
"disclosure_date": "2014-03-20",
"first_cert_date": "2012-03-27",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-03-27 ~ 2016-03-26"
},
{
"cert_number": "20160105786",
"changes": "",
"disclosure_date": "2016-05-17",
"first_cert_date": "2012-03-27",
"no": "3",
"type": "연구개발유형",
"valid_period": "2016-03-27 ~ 2018-03-26"
},
{
"cert_number": "20180102860",
"changes": "",
"disclosure_date": "2018-03-20",
"first_cert_date": "2012-03-27",
"no": "4",
"type": "연구개발유형",
"valid_period": "2018-03-27 ~ 2020-03-26"
},
{
"cert_number": "20200300202",
"changes": "",
"disclosure_date": "2020-02-27",
"first_cert_date": "2012-03-27",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2020-03-27 ~ 2022-03-26"
},
{
"cert_number": "20220428010023",
"changes": "",
"disclosure_date": "2022-04-28",
"first_cert_date": "2012-03-27",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2022-03-27 ~ 2025-03-26"
},
{
"cert_number": "20250429010010",
"changes": "",
"disclosure_date": "2025-04-29",
"first_cert_date": "2012-03-27",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2025-03-27 ~ 2028-03-26"
}
],
"company_name": "(주)세포바이오",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 6515602000,
"cost_of_sales": 639650000,
"current_assets": 1647191000,
"current_liabilities": 20606225000,
"gross_profit": 798780000,
"net_income": -7226246000,
"net_income_bs": -7226246000,
"non_current_assets": 2953342000,
"non_current_liabilities": 1116697000,
"non_operating_expenses": 3108612000,
"non_operating_income": 209923000,
"operating_profit": -4327557000,
"revenue": 1438430000,
"sga_expenses": 5126337000,
"total_assets": 4600533000,
"total_equity": -17122389000,
"total_liabilities": 21722922000
},
"2023": {
"capital_stock": 8994999000,
"cost_of_sales": 357342000,
"current_assets": 2233523000,
"current_liabilities": 22500644000,
"gross_profit": 1050252000,
"net_income": -3844453000,
"net_income_bs": -3844453000,
"non_current_assets": 2366392000,
"non_current_liabilities": 89828000,
"non_operating_expenses": 3028215000,
"non_operating_income": 4805995000,
"operating_profit": -5622233000,
"revenue": 1407594000,
"sga_expenses": 6672485000,
"total_assets": 4599915000,
"total_equity": -17990557000,
"total_liabilities": 22590472000
},
"2024": {
"capital_stock": 816770000,
"cost_of_sales": 650302000,
"current_assets": 1027766000,
"current_liabilities": 30438632000,
"gross_profit": 1579010000,
"net_income": -1998974000,
"net_income_bs": -1998974000,
"non_current_assets": 1478724000,
"non_current_liabilities": 235618000,
"non_operating_expenses": 169248000,
"non_operating_income": 27730000,
"operating_profit": -1857456000,
"revenue": 2229312000,
"sga_expenses": 3436466000,
"total_assets": 2506490000,
"total_equity": -28167760000,
"total_liabilities": 30674250000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [
{
"amount": "1,499,995,000",
"changes": "1,499,995,000",
"date": "2023-03-27"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2021-07-15"
},
{
"amount": "2,999,940,000",
"changes": "2,999,940,000",
"date": "2018-04-30"
},
{
"amount": "3,000,000,000",
"changes": "3,000,000,000",
"date": "2018-04-30"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2018-04-30"
},
{
"amount": "971,000,000",
"changes": "971,000,000",
"date": "2016-11-03"
}
],
"main_products": "세포,배지",
"phone": "02-723-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |